These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative. de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events. Rosseto LA; Pires ME; Melchior AC; Bosquesi PL; Pavan AR; Marcondes S; Chung MC; Santos JL Molecules; 2015 Oct; 20(10):18185-200. PubMed ID: 26457696 [TBL] [Abstract][Full Text] [Related]
4. Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana Riezk A; Raynes JG; Yardley V; Murdan S; Croft SL Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871082 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones. Maciel-Rezende CM; de Almeida L; Costa ÉD; Pires FR; Alves KF; Viegas C; Dias DF; Doriguetto AC; Marques MJ; dos Santos MH Bioorg Med Chem; 2013 Jun; 21(11):3114-9. PubMed ID: 23623672 [TBL] [Abstract][Full Text] [Related]
6. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis. Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571 [TBL] [Abstract][Full Text] [Related]
7. In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis. da Silva ET; de Andrade GF; Araújo ADS; Almeida ADC; Coimbra ES; de Souza MVN Acta Parasitol; 2020 Mar; 65(1):203-207. PubMed ID: 31832921 [TBL] [Abstract][Full Text] [Related]
15. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents. Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity. Clementino LDC; Fernandes GFS; Prokopczyk IM; Laurindo WC; Toyama D; Motta BP; Baviera AM; Henrique-Silva F; Santos JLD; Graminha MAS PLoS One; 2021; 16(11):e0259008. PubMed ID: 34723989 [TBL] [Abstract][Full Text] [Related]
17. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis. da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563 [TBL] [Abstract][Full Text] [Related]
18. Effect of the anti-microtubule compound tubulozole on Leishmania protozoan parasites in vitro. Fong D FEMS Microbiol Lett; 1993 Feb; 107(1):95-9. PubMed ID: 8468004 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of thiadiazine derivatives against Leishmania amazonensis. Monzote L; Montalvo AM; Fonseca L; Pérez R; Suárez M; Rodríguez H Arzneimittelforschung; 2005; 55(4):232-8. PubMed ID: 15901047 [TBL] [Abstract][Full Text] [Related]
20. An effective diaryl derivative against Leishmania amazonensis and its influence on the parasite X macrophage interaction. Alves LV; Cysne-Finkelstein L; Temporal RM; Genestra MS; Leon LL J Enzyme Inhib Med Chem; 2004 Oct; 19(5):437-9. PubMed ID: 15648659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]